By SHEILA KAPLAN and JAN HOFFMAN from NYT Health https://ift.tt/2GYuoss
Initially criticized for his ties to the pharmaceutical industry, Gottlieb, a former venture capitalist, became known for his aggressive regulatory stance in the Trump administration.
No comments:
Post a Comment